87S.F - Roivant Sciences Ltd.

Frankfurt - Frankfurt Delayed price. Currency in EUR
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
Cash flows from operating activities
Net income
-1,245,475
-845,262
-809,234
Stock-based compensation
269,663
564,956
84,958
Change in working capital
22,731
15,719
71,938
Accounts payable
25,680
15,403
3,752
Other working capital
-829,105
-695,165
-557,944
Other non-cash items
141,199
88,688
398,346
Net cash provided by operating activities
-811,774
-677,729
-552,138
Cash flows from investing activities
Investments in property, plant and equipment
-17,331
-17,436
-5,806
Sales/maturities of investments
0
320,170
0
Other investing activities
-
561
-25,896
Net cash used for investing activities
-163,524
303,295
-31,702
Cash flows from financing activities
Debt repayment
-22,108
-21,590
0
Common stock issued
162,462
0
455,756
Other financing activities
-12,869
291,982
508
Net cash used provided by (used for) financing activities
290,200
306,792
456,264
Net change in cash
-685,098
-67,642
-127,576
Cash at beginning of period
2,226,135
2,141,676
2,269,252
Cash at end of period
1,541,037
2,074,034
2,141,676
Free cash flow
Operating cash flow
-811,774
-677,729
-552,138
Capital expenditure
-17,331
-17,436
-5,806
Free cash flow
-829,105
-695,165
-557,944